Human biology in action: advancing drug discovery with NAMs

New approach methodologies (NAMs) using human-cell-based models like iPSC and organoids are improving the physiological relevance of drug discovery preclinical research, helping translational accuracy, safety assessment, and pharmacology evaluation while efforts continue to establish standards for broader regulatory confidence and adoption.

This Wire brief sits within Fusion42's coverage of Drug Discovery and Biotech.